By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:



Company News
Ignyta (RXDX) Announces FDA Clearance Of IND For RXDX-107 7/29/2015 11:16:27 AM
Ignyta (RXDX) Boosts Leadership Capacity With Appointment Of Bernard Parker As Chief Commercial Officer 7/22/2015 10:21:45 AM
Ignyta (RXDX) Announces Collaboration With University of California, San Francisco (UCSF) For Clinical Trial Of Entrectinib 7/7/2015 10:40:36 AM
Ignyta (RXDX) To Present At Cantor Fitzgerald Healthcare Conference 7/6/2015 11:24:14 AM
Ignyta (RXDX) Announces The Release For Clinical Use Of A Proprietary NGS Clinical Trial Assay To Support Its STARTRK Clinical Studies 6/30/2015 1:20:32 PM
Ignyta (RXDX) Added To Russell 2000 Index 6/30/2015 12:04:35 PM
Ignyta (RXDX) Announces Proposed Public Offering Of $75 Million Of Common Stock 6/10/2015 12:20:34 PM
Ignyta (RXDX) Announces Phase 1 Clinical Trial Data For Entrectinib 6/1/2015 11:09:34 AM
Ignyta (RXDX) To Present At 2015 Jefferies and Co. Healthcare Conference 5/28/2015 8:26:21 AM
Ignyta (RXDX) Announces Two Entrectinib Phase I Data Presentations And Webcast Management Presentation At The 2015 ASCO Annual Meeting 5/20/2015 12:03:52 PM